Cite
APA Citation
Reis, H., Herold, T., Ting, S., Worm, K., Huber, U., Christoph, D., Eberhardt, W., Kostbade, K., Kasper, S., Stamatis, G., Welter, S., Darwiche, K., Karpf-Wissel, R., Theegarten, D., Schmid, K., Schuler, M., & Wiesweg, M. (n.d.). hER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas. Lung cancer, 88(1), 34–41. http://access.bl.uk/ark:/81055/vdc_100031248546.0x00002d